 | • レポートコード：QY2108PAL8930 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける制限エンドヌクレアーゼの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、制限エンドヌクレアーゼの種類別市場規模（タイプI、タイプII、タイプIII、タイプIV、その他）、用途別市場規模（学術・研究機関、病院・診断センター、バイオ医薬品、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の制限エンドヌクレアーゼ市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における制限エンドヌクレアーゼの種類別市場規模（2016年-2027年）：タイプI、タイプII、タイプIII、タイプIV、その他 ・世界における制限エンドヌクレアーゼの用途別市場規模（2016年-2027年）：学術・研究機関、病院・診断センター、バイオ医薬品、その他 ・制限エンドヌクレアーゼの中国市場分析 - 制限エンドヌクレアーゼの中国市場規模（2016年-2027年） - 中国における制限エンドヌクレアーゼの主要プレイヤー別市場シェア - 中国における制限エンドヌクレアーゼの種類別市場規模：タイプI、タイプII、タイプIII、タイプIV、その他 - 中国における制限エンドヌクレアーゼの用途別市場規模：学術・研究機関、病院・診断センター、バイオ医薬品、その他 ・制限エンドヌクレアーゼの北米市場（2016年-2027年） ・制限エンドヌクレアーゼのヨーロッパ市場（2016年-2027年） ・制限エンドヌクレアーゼのアジア太平洋市場（2016年-2027年） ・制限エンドヌクレアーゼの中南米市場（2016年-2027年） ・制限エンドヌクレアーゼの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：New England Biolabs、Thermo Fisher Scientific、Takara Bio、Illumina、Agilent、Roche、GE Healthcare、Promega、Qiagen、Jena Biosciences ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.
The Restriction Endonuclease industry is relatively concentrated, and the players mainly come from North America and Western Europe. In the world wide, major manufactures mainly are New England Biolabs, Thermo Fisher Scientific, Takara Bio, Illumina, Agilent Technologies, Roche, GE Healthcare, Promega Corporation, Qiagen and Jena Biosciences, etc, with about 88% market shares.
Market Analysis and Insights: Global and China Restriction Endonucleases Market
This report focuses on global and China Restriction Endonucleases market.
In 2020, the global Restriction Endonucleases market size was US$ 254.8 million and it is expected to reach US$ 378.1 million by the end of 2027, with a CAGR of 5.8% during 2021-2027. In China the Restriction Endonucleases market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Restriction Endonucleases Scope and Market Size
Restriction Endonucleases market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Restriction Endonucleases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Restriction Endonucleases market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Type I
Type II
Type III
Type IV
Others
Segment by Application
Academic & Research Institutes
Hospitals & Diagnostic Centers
Biopharmaceutical
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent
Roche
GE Healthcare
Promega
Qiagen
Jena Biosciences
1 Study Coverage
1.1 Restriction Endonucleases Product Introduction
1.2 Market by Type
1.2.1 Global Restriction Endonucleases Market Size Growth Rate by Type
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.2.5 Type IV
1.2.6 Others
1.3 Market by Application
1.3.1 Global Restriction Endonucleases Market Size Growth Rate by Application
1.3.2 Academic & Research Institutes
1.3.3 Hospitals & Diagnostic Centers
1.3.4 Biopharmaceutical
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Restriction Endonucleases Market Size, Estimates and Forecasts
2.1.1 Global Restriction Endonucleases Revenue 2016-2027
2.1.2 Global Restriction Endonucleases Sales 2016-2027
2.2 Global Restriction Endonucleases, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Restriction Endonucleases Historical Market Size by Region (2016-2021)
2.3.1 Global Restriction Endonucleases Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Restriction Endonucleases Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Restriction Endonucleases Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Restriction Endonucleases Sales Forecast by Region (2022-2027)
2.4.2 Global Restriction Endonucleases Revenue Forecast by Region (2022-2027)
3 Global Restriction Endonucleases Competitor Landscape by Players
3.1 Global Top Restriction Endonucleases Manufacturers by Sales
3.1.1 Global Restriction Endonucleases Sales by Manufacturer (2016-2021)
3.1.2 Global Restriction Endonucleases Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Restriction Endonucleases Manufacturers by Revenue
3.2.1 Key Restriction Endonucleases Manufacturers Covered: Ranking by Revenue
3.2.2 Global Restriction Endonucleases Revenue by Manufacturers (2016-2021)
3.2.3 Global Restriction Endonucleases Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Restriction Endonucleases Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Restriction Endonucleases Revenue in 2020
3.2.6 Global Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Restriction Endonucleases Price by Manufacturers
3.4 Global Restriction Endonucleases Manufacturing Base Distribution, Product Types
3.4.1 Restriction Endonucleases Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Restriction Endonucleases Product Type
3.4.3 Date of International Manufacturers Enter into Restriction Endonucleases Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Restriction Endonucleases Market Size by Type (2016-2021)
4.1.1 Global Restriction Endonucleases Sales by Type (2016-2021)
4.1.2 Global Restriction Endonucleases Revenue by Type (2016-2021)
4.1.3 Restriction Endonucleases Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Restriction Endonucleases Market Size Forecast by Type (2022-2027)
4.2.1 Global Restriction Endonucleases Sales Forecast by Type (2022-2027)
4.2.2 Global Restriction Endonucleases Revenue Forecast by Type (2022-2027)
4.2.3 Restriction Endonucleases Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Restriction Endonucleases Market Size by Application (2016-2021)
5.1.1 Global Restriction Endonucleases Sales by Application (2016-2021)
5.1.2 Global Restriction Endonucleases Revenue by Application (2016-2021)
5.1.3 Restriction Endonucleases Price by Application (2016-2021)
5.2 Restriction Endonucleases Market Size Forecast by Application (2022-2027)
5.2.1 Global Restriction Endonucleases Sales Forecast by Application (2022-2027)
5.2.2 Global Restriction Endonucleases Revenue Forecast by Application (2022-2027)
5.2.3 Global Restriction Endonucleases Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Restriction Endonucleases Market Size YoY Growth 2016-2027
6.1.1 China Restriction Endonucleases Sales YoY Growth 2016-2027
6.1.2 China Restriction Endonucleases Revenue YoY Growth 2016-2027
6.1.3 China Restriction Endonucleases Market Share in Global Market 2016-2027
6.2 China Restriction Endonucleases Market Size by Players (International and Local Players)
6.2.1 China Top Restriction Endonucleases Players by Sales (2016-2021)
6.2.2 China Top Restriction Endonucleases Players by Revenue (2016-2021)
6.3 China Restriction Endonucleases Historic Market Review by Type (2016-2021)
6.3.1 China Restriction Endonucleases Sales Market Share by Type (2016-2021)
6.3.2 China Restriction Endonucleases Revenue Market Share by Type (2016-2021)
6.3.3 China Restriction Endonucleases Price by Type (2016-2021)
6.4 China Restriction Endonucleases Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Restriction Endonucleases Sales Forecast by Type (2022-2027)
6.4.2 China Restriction Endonucleases Revenue Forecast by Type (2022-2027)
6.4.3 China Restriction Endonucleases Price Forecast by Type (2022-2027)
6.5 China Restriction Endonucleases Historic Market Review by Application (2016-2021)
6.5.1 China Restriction Endonucleases Sales Market Share by Application (2016-2021)
6.5.2 China Restriction Endonucleases Revenue Market Share by Application (2016-2021)
6.5.3 China Restriction Endonucleases Price by Application (2016-2021)
6.6 China Restriction Endonucleases Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Restriction Endonucleases Sales Forecast by Application (2022-2027)
6.6.2 China Restriction Endonucleases Revenue Forecast by Application (2022-2027)
6.6.3 China Restriction Endonucleases Price Forecast by Application (2022-2027)
7 North America
7.1 North America Restriction Endonucleases Market Size YoY Growth 2016-2027
7.2 North America Restriction Endonucleases Market Facts & Figures by Country
7.2.1 North America Restriction Endonucleases Sales by Country (2016-2021)
7.2.2 North America Restriction Endonucleases Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Restriction Endonucleases Market Size YoY Growth 2016-2027
8.2 Asia Pacific Restriction Endonucleases Market Facts & Figures by Region
8.2.1 Asia Pacific Restriction Endonucleases Sales by Region (2016-2021)
8.2.2 Asia Pacific Restriction Endonucleases Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Restriction Endonucleases Market Size YoY Growth 2016-2027
9.2 Europe Restriction Endonucleases Market Facts & Figures by Country
9.2.1 Europe Restriction Endonucleases Sales by Country (2016-2021)
9.2.2 Europe Restriction Endonucleases Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Restriction Endonucleases Market Size YoY Growth 2016-2027
10.2 Latin America Restriction Endonucleases Market Facts & Figures by Country
10.2.1 Latin America Restriction Endonucleases Sales by Country (2016-2021)
10.2.2 Latin America Restriction Endonucleases Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Restriction Endonucleases Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Restriction Endonucleases Market Facts & Figures by Country
11.2.1 Middle East and Africa Restriction Endonucleases Sales by Country (2016-2021)
11.2.2 Middle East and Africa Restriction Endonucleases Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 New England Biolabs
12.1.1 New England Biolabs Corporation Information
12.1.2 New England Biolabs Description and Business Overview
12.1.3 New England Biolabs Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.1.4 New England Biolabs Restriction Endonucleases Products Offered
12.1.5 New England Biolabs Recent Development
12.2 Thermo Fisher Scientific
12.2.1 Thermo Fisher Scientific Corporation Information
12.2.2 Thermo Fisher Scientific Description and Business Overview
12.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Thermo Fisher Scientific Restriction Endonucleases Products Offered
12.2.5 Thermo Fisher Scientific Recent Development
12.3 Takara Bio
12.3.1 Takara Bio Corporation Information
12.3.2 Takara Bio Description and Business Overview
12.3.3 Takara Bio Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takara Bio Restriction Endonucleases Products Offered
12.3.5 Takara Bio Recent Development
12.4 Illumina
12.4.1 Illumina Corporation Information
12.4.2 Illumina Description and Business Overview
12.4.3 Illumina Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Illumina Restriction Endonucleases Products Offered
12.4.5 Illumina Recent Development
12.5 Agilent
12.5.1 Agilent Corporation Information
12.5.2 Agilent Description and Business Overview
12.5.3 Agilent Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Agilent Restriction Endonucleases Products Offered
12.5.5 Agilent Recent Development
12.6 Roche
12.6.1 Roche Corporation Information
12.6.2 Roche Description and Business Overview
12.6.3 Roche Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Roche Restriction Endonucleases Products Offered
12.6.5 Roche Recent Development
12.7 GE Healthcare
12.7.1 GE Healthcare Corporation Information
12.7.2 GE Healthcare Description and Business Overview
12.7.3 GE Healthcare Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GE Healthcare Restriction Endonucleases Products Offered
12.7.5 GE Healthcare Recent Development
12.8 Promega
12.8.1 Promega Corporation Information
12.8.2 Promega Description and Business Overview
12.8.3 Promega Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Promega Restriction Endonucleases Products Offered
12.8.5 Promega Recent Development
12.9 Qiagen
12.9.1 Qiagen Corporation Information
12.9.2 Qiagen Description and Business Overview
12.9.3 Qiagen Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Qiagen Restriction Endonucleases Products Offered
12.9.5 Qiagen Recent Development
12.10 Jena Biosciences
12.10.1 Jena Biosciences Corporation Information
12.10.2 Jena Biosciences Description and Business Overview
12.10.3 Jena Biosciences Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jena Biosciences Restriction Endonucleases Products Offered
12.10.5 Jena Biosciences Recent Development
12.11 New England Biolabs
12.11.1 New England Biolabs Corporation Information
12.11.2 New England Biolabs Description and Business Overview
12.11.3 New England Biolabs Restriction Endonucleases Sales, Revenue and Gross Margin (2016-2021)
12.11.4 New England Biolabs Restriction Endonucleases Products Offered
12.11.5 New England Biolabs Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Restriction Endonucleases Industry Trends
13.2 Restriction Endonucleases Market Drivers
13.3 Restriction Endonucleases Market Challenges
13.4 Restriction Endonucleases Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Restriction Endonucleases Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Restriction Endonucleases Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of Type II
Table 4. Major Manufacturers of Type III
Table 5. Major Manufacturers of Type IV
Table 6. Major Manufacturers of Others
Table 7. Global Restriction Endonucleases Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Restriction Endonucleases Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Restriction Endonucleases Sales by Regions (2016-2021) & (K Units)
Table 10. Global Restriction Endonucleases Sales Market Share by Regions (2016-2021)
Table 11. Global Restriction Endonucleases Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Restriction Endonucleases Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Restriction Endonucleases Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Restriction Endonucleases Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Restriction Endonucleases Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Restriction Endonucleases Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Restriction Endonucleases Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Restriction Endonucleases Manufacturers by Revenue (US$ Million) in 2020
Table 19. Restriction Endonucleases Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Restriction Endonucleases Revenue Share by Manufacturers (2016-2021)
Table 21. Global Restriction Endonucleases Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Restriction Endonucleases by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Restriction Endonucleases as of 2020)
Table 23. Key Manufacturers Restriction Endonucleases Price (2016-2021) (USD/Unit)
Table 24. Restriction Endonucleases Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Restriction Endonucleases Product Type
Table 26. Date of International Manufacturers Enter into Restriction Endonucleases Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Restriction Endonucleases Sales by Type (2016-2021) (K Units)
Table 29. Global Restriction Endonucleases Sales Share by Type (2016-2021)
Table 30. Global Restriction Endonucleases Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Restriction Endonucleases Revenue Share by Type (2016-2021)
Table 32. Restriction Endonucleases Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Restriction Endonucleases Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Restriction Endonucleases Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Restriction Endonucleases Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Restriction Endonucleases Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Restriction Endonucleases Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Restriction Endonucleases Sales by Application (2016-2021) (K Units)
Table 39. Global Restriction Endonucleases Sales Share by Application (2016-2021)
Table 40. Global Restriction Endonucleases Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Restriction Endonucleases Revenue Share by Application (2016-2021)
Table 42. Restriction Endonucleases Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Restriction Endonucleases Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Restriction Endonucleases Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Restriction Endonucleases Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Restriction Endonucleases Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Restriction Endonucleases Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. China Restriction Endonucleases Sales (K Units) of Key Companies (2016-2021)
Table 49. China Restriction Endonucleases Sales Share by Company (2016-2021)
Table 50. China Restriction Endonucleases Revenue (US$ Million) by Company (2016-2021)
Table 51. China Restriction Endonucleases Revenue Share by Company (2016-2021)
Table 52. China Restriction Endonucleases Sales (K Units) by Type (2016-2021)
Table 53. China Restriction Endonucleases Sales Share by Type (2016-2021)
Table 54. China Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. China Restriction Endonucleases Price (USD/Unit) by Type (2016-2021)
Table 56. China Restriction Endonucleases Sales (K Units) by Type (2022-2027)
Table 57. China Restriction Endonucleases Sales Share by Type (2022-2027)
Table 58. China Restriction Endonucleases Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. China Restriction Endonucleases Revenue Share by Type (2022-2027)
Table 60. China Restriction Endonucleases Price (USD/Unit) by Type (2022-2027)
Table 61. China Restriction Endonucleases Sales (K Units) by Application (2016-2021)
Table 62. China Restriction Endonucleases Sales Share by Application (2016-2021)
Table 63. China Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. China Restriction Endonucleases Price (USD/Unit) by Application (2016-2021)
Table 65. China Restriction Endonucleases Sales (K Units) by Application (2022-2027)
Table 66. China Restriction Endonucleases Sales Share by Application (2022-2027)
Table 67. China Restriction Endonucleases Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. China Restriction Endonucleases Revenue Share by Application (2022-2027)
Table 69. China Restriction Endonucleases Price (USD/Unit) by Application (2022-2027)
Table 70. North America Restriction Endonucleases Sales by Country (2016-2021) & (K Units)
Table 71. North America Restriction Endonucleases Sales Market Share by Country (2016-2021)
Table 72. North America Restriction Endonucleases Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Restriction Endonucleases Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Restriction Endonucleases Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Restriction Endonucleases Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Restriction Endonucleases Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Restriction Endonucleases Revenue Market Share by Region (2016-2021)
Table 78. Europe Restriction Endonucleases Sales by Country (2016-2021) & (K Units)
Table 79. Europe Restriction Endonucleases Sales Market Share by Country (2016-2021)
Table 80. Europe Restriction Endonucleases Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Restriction Endonucleases Revenue Market Share by Country (2016-2021)
Table 82. Latin America Restriction Endonucleases Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Restriction Endonucleases Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Restriction Endonucleases Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Restriction Endonucleases Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Restriction Endonucleases Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Restriction Endonucleases Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Restriction Endonucleases Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Restriction Endonucleases Revenue Market Share by Country (2016-2021)
Table 90. New England Biolabs Corporation Information
Table 91. New England Biolabs Description and Business Overview
Table 92. New England Biolabs Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. New England Biolabs Restriction Endonucleases Product
Table 94. New England Biolabs Recent Development
Table 95. Thermo Fisher Scientific Corporation Information
Table 96. Thermo Fisher Scientific Description and Business Overview
Table 97. Thermo Fisher Scientific Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. Thermo Fisher Scientific Product
Table 99. Thermo Fisher Scientific Recent Development
Table 100. Takara Bio Corporation Information
Table 101. Takara Bio Description and Business Overview
Table 102. Takara Bio Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Takara Bio Product
Table 104. Takara Bio Recent Development
Table 105. Illumina Corporation Information
Table 106. Illumina Description and Business Overview
Table 107. Illumina Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Illumina Product
Table 109. Illumina Recent Development
Table 110. Agilent Corporation Information
Table 111. Agilent Description and Business Overview
Table 112. Agilent Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Agilent Product
Table 114. Agilent Recent Development
Table 115. Roche Corporation Information
Table 116. Roche Description and Business Overview
Table 117. Roche Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Roche Product
Table 119. Roche Recent Development
Table 120. GE Healthcare Corporation Information
Table 121. GE Healthcare Description and Business Overview
Table 122. GE Healthcare Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. GE Healthcare Product
Table 124. GE Healthcare Recent Development
Table 125. Promega Corporation Information
Table 126. Promega Description and Business Overview
Table 127. Promega Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Promega Product
Table 129. Promega Recent Development
Table 130. Qiagen Corporation Information
Table 131. Qiagen Description and Business Overview
Table 132. Qiagen Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Qiagen Product
Table 134. Qiagen Recent Development
Table 135. Jena Biosciences Corporation Information
Table 136. Jena Biosciences Description and Business Overview
Table 137. Jena Biosciences Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Jena Biosciences Product
Table 139. Jena Biosciences Recent Development
Table 140. Restriction Endonucleases Market Trends
Table 141. Restriction Endonucleases Market Drivers
Table 142. Restriction Endonucleases Market Challenges
Table 143. Restriction Endonucleases Market Restraints
Table 144. Restriction Endonucleases Customers List
Table 145. Restriction Endonucleases Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Restriction Endonucleases Product Picture
Figure 2. Global Restriction Endonucleases Sales Market Share by Type in 2020 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Type III Product Picture
Figure 6. Type IV Product Picture
Figure 7. Others Product Picture
Figure 8. Global Restriction Endonucleases Sales Market Share by Application in 2020 & 2027
Figure 9. Academic & Research Institutes
Figure 10. Hospitals & Diagnostic Centers
Figure 11. Biopharmaceutical
Figure 12. Others
Figure 13. Restriction Endonucleases Report Years Considered
Figure 14. Global Restriction Endonucleases Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Restriction Endonucleases Market Size 2016-2027 (US$ Million)
Figure 16. Global Restriction Endonucleases Sales 2016-2027 (K Units)
Figure 17. Global Restriction Endonucleases Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Restriction Endonucleases Sales Market Share by Region (2016-2021)
Figure 19. Global Restriction Endonucleases Sales Market Share by Region in 2020
Figure 20. Global Restriction Endonucleases Revenue Market Share by Region (2016-2021)
Figure 21. Global Restriction Endonucleases Revenue Market Share by Region in 2020
Figure 22. Global Restriction Endonucleases Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Restriction Endonucleases Revenue in 2020
Figure 24. Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Restriction Endonucleases Sales Market Share by Type (2016-2021)
Figure 26. Global Restriction Endonucleases Sales Market Share by Type in 2020
Figure 27. Global Restriction Endonucleases Revenue Market Share by Type (2016-2021)
Figure 28. Global Restriction Endonucleases Revenue Market Share by Type in 2020
Figure 29. Global Restriction Endonucleases Sales Market Share by Application (2016-2021)
Figure 30. Global Restriction Endonucleases Sales Market Share by Application in 2020
Figure 31. Global Restriction Endonucleases Revenue Market Share by Application (2016-2021)
Figure 32. Global Restriction Endonucleases Revenue Market Share by Application in 2020
Figure 33. China Restriction Endonucleases Sales Growth Rate 2016-2027 (K Units)
Figure 34. China Restriction Endonucleases Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Restriction Endonucleases Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Restriction Endonucleases Players Market Share by Revenue in Restriction Endonucleases in 2020
Figure 37. China Restriction Endonucleases Revenue Share by Type (2016-2021)
Figure 38. China Restriction Endonucleases Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Restriction Endonucleases Revenue Share by Application (2016-2021)
Figure 40. China Restriction Endonucleases Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Restriction Endonucleases Sales Growth Rate 2016-2021 (K Units)
Figure 42. North America Restriction Endonucleases Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Restriction Endonucleases Sales Market Share by Country in 2020
Figure 44. North America Restriction Endonucleases Revenue Market Share by Country in 2020
Figure 45. U.S. Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 46. U.S. Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 48. Canada Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Restriction Endonucleases Sales Growth Rate 2016-2021 (K Units)
Figure 50. Europe Restriction Endonucleases Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Restriction Endonucleases Sales Market Share by Country in 2020
Figure 52. Europe Restriction Endonucleases Revenue Market Share by Country in 2020
Figure 53. Germany Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 54. Germany Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 56. France Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 58. U.K. Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 60. Italy Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 62. Russia Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Restriction Endonucleases Sales Growth Rate 2016-2021 (K Units)
Figure 64. Asia Pacific Restriction Endonucleases Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Restriction Endonucleases Sales Market Share by Region in 2020
Figure 66. Asia Pacific Restriction Endonucleases Revenue Market Share by Region in 2020
Figure 67. China Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 68. China Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 70. Japan Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 72. South Korea Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 74. India Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 76. Australia Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 78. Taiwan Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 80. Indonesia Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 82. Thailand Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 84. Malaysia Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 86. Philippines Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 88. Vietnam Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Restriction Endonucleases Sales Growth Rate 2016-2021 (K Units)
Figure 90. Latin America Restriction Endonucleases Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Restriction Endonucleases Sales Market Share by Country in 2020
Figure 92. Latin America Restriction Endonucleases Revenue Market Share by Country in 2020
Figure 93. Mexico Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 94. Mexico Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 96. Brazil Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Argentina Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 98. Argentina Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Middle East and Africa Restriction Endonucleases Sales Growth Rate 2016-2021 (K Units)
Figure 100. Middle East and Africa Restriction Endonucleases Revenue Growth Rate 2016-2021 (US$ Million)
Figure 101. Middle East and Africa Restriction Endonucleases Sales Market Share by Country in 2020
Figure 102. Middle East and Africa Restriction Endonucleases Revenue Market Share by Country in 2020
Figure 103. Turkey Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 104. Turkey Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Saudi Arabia Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 106. Saudi Arabia Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. U.A.E Restriction Endonucleases Sales Growth Rate (2016-2021) (K Units)
Figure 108. U.A.E Restriction Endonucleases Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. Restriction Endonucleases Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Bottom-up and Top-down Approaches for This Report
Figure 113. Data Triangulation
Figure 114. Key Executives Interviewed
制限酵素の世界市場 2020年 Market Overview The Restriction Endonucleases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 血流制限バンドの世界市場 2020年 Market Overview The global Blood Flow Restriction Band market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Blood Flow Restri…
- 分子生物学酵素・キット・試薬の世界市場 2020年 Market Overview The global Molecular Biology Enzymes, Kits & Reagents market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mo…
- バイオ医薬品及びワクチン生産の世界市場 2020年 Market Overview The global Biopharmaceutical and Vaccine Production market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Biop…
- 子宮がん治療・診断の世界市場 2020年 Market Overview The global Uterine Cancer Therapies and Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uteri…